TCW Q2 Letter: S&P 500 Hits Highs on AI Capex, BSX Lags
TCW's Q2 2026 letter reviews market gains driven by AI capex and earnings, but flags Boston Scientific's underperformance due to weak Watchman/EP results and lowered 2026 guidance despite positive CH…